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Mitochondrial respiratory chain function and content are preserved in the skeletal 
muscle of active very old men and women 
(Short: Mitochondrial function and content in the active very old) 
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Abstract 
Introduction 
The loss of mitochondrial function and content have been implicated in sarcopenia although 
they have been little studied in the very old, the group in which sarcopenia is most common. 
In this pilot study, our aim was to determine if mitochondrial respiratory chain function and 
content are preserved among healthy 85-year-olds. 
Methods 
We recruited 19 participants (11 female) through their general practitioner and assessed their 
medical history, functional status and self-reported physical activity. We identified 
sarcopenia using grip strength, Timed Up-and-Go and bioimpedance analysis. We assessed 
mitochondrial respiratory chain function using phosphorous magnetic resonance 
spectroscopy, estimating 1/2 PCr, the recovery half-time of phosphocreatine in the calf 
muscles following a bout of aerobic exercise. We performed a biopsy of the vastus lateralis 
muscle and assessed mitochondrial respiratory chain content by measuring levels of subunits 
of complex I and IV of the respiratory chain, expressed as Z-scores relative to that in young 
controls. 
Results 
Participants had a median (IQR) of 2 (1,3) long-term conditions, reported regular aerobic 
physical activity, and one participant (5.3%) had sarcopenia. Sixteen participants completed 
the magnetic resonance protocol and the mean (SD) 1/2 PCr of 35.6 (11.3) seconds was in 
keeping with preserved mitochondrial function. Seven participants underwent muscle biopsy 
and the mean fibre Z-scores were -0.7 (0.7) and -0.2 (0.4) for complexes I and IV, 
respectively, suggesting preserved content of mitochondrial respiratory chain enzymes. 
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Conclusion 
Muscle mitochondrial respiratory chain function and content are preserved in a sample of 
active, well-functioning 85-year-olds, among whom sarcopenia was uncommon. The results 
from this study will help inform future work examining the association between muscle 
mitochondrial deficiency and sarcopenia.  
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Introduction  
Impairments in skeletal muscle mitochondrial function and content have been implicated in 
the development of sarcopenia, the age-related loss of muscle mass and performance [1–3]. 
The assessment of skeletal muscle mitochondria presents challenges. Assessment of content, 
such as staining for cytochrome oxidase, requires the collection of muscle tissue, as do in 
vitro measures of function such as respirometry of isolated mitochondria [4]. In vivo 
measurement of function is possible using phosphorous magnetic resonance spectroscopy 
(
31
P-MRS), requiring participants to undertake controlled exercise sufficient to deplete 
muscle reserves of phosphocreatine [5].  
 
As expected for an age-related condition, sarcopenia is most common among the very old [6], 
with a prevalence of 21% in a sample of 85-year-olds [7]. There have been few studies of 
mitochondrial function and content in this age group, with relevant studies typically having a 
mean age below 85 [8–12]. The opportunity to collect muscle samples during hip fracture 
surgery has been used to investigate whether impaired mitochondrial homeostasis is 
associated with sarcopenia among the very old [13]. Older patients with hip fracture are 
recognised to have not only high levels of sarcopenia but also disability and multimorbidity 
[14,15]; in this setting, the influences of ageing per se and those of acute illness and overall 
frailty may be difficult to disentangle.  
 
A complementary approach is to study community-dwelling very old individuals, including 
those with few medical and functional problems, who may provide important insights into 
factors that promote healthy ageing [16]. We therefore undertook a pilot study in which we 
assessed the feasibility of recruiting community-dwelling 85-year-old people to attend for 
detailed phenotyping including 
31
P-MRS and muscle biopsy. The aim of the present study 
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was to determine if skeletal muscle mitochondrial respiratory chain function and content are 
preserved among healthy 85-year-olds.  
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Methods 
Participants 
We recruited participants aged 85 years, born in 1931, who were registered with a general 
practice within the North East & North Cumbria Clinical Research Network, England. We 
excluded those with a cardiac pacemaker or any other metallic or programmable device (e.g. 
cochlear implants or surgical clips) or those who were taking anticoagulant drugs. We also 
excluded individuals considered unsuitable for approach by their general practitioner (GP). 
All participants needed to have capacity to provide written informed consent. 
   
Potential participants were identified through their GPs and were sent a letter of invitation, a 
study information pack and a letter of support from their GP. Individuals expressing an 
interest in the study were then contacted by the research team and an appointment made to 
visit them in their own home. At this visit, the requirements of the study were discussed in 
detail and initial informed consent obtained. Endurance of consent was verified at each 
contact and prior to any research procedure throughout the research process. The study was 
approved in the UK by the Tyne & Wear South Research Ethics Committee (15/NE/0382). 
Fieldwork took place between May and August 2016.  
 
We asked participants whether they had ever been diagnosed by a doctor with 11 common 
conditions (heart attack, congestive heart failure, angina, stroke / mini-stroke / TIA, 
hypertension, diabetes, asthma, depression, chronic lung disease, kidney disease or cancer) 
and recorded their regular prescribed medications. We used the 15-item geriatric depression 
scale (GDS) and the mini-mental state examination (MMSE) to assess mood and cognition, 
respectively. We enquired about difficulty or needing help across 17 activities of daily living 
such as dressing/undressing, cutting toenails, shopping and managing finances. We used the 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
Page 7 of 22 
Short Form 36 (SF-36) Health Survey Questionnaire to derive general health and physical 
functioning scores [17]. We assessed physical activity using the rapid assessment of physical 
activity (RAPA), deriving scores for aerobic activity (1-7, with 7 being most active) and 
strength and flexibility activity (0-3, with 3 most being active) [18]. 
 
Identification of sarcopenia 
We measured grip strength (kg) with a Jamar handheld hydraulic dynamometer (Promedics, 
UK) using three trials in both hands following a standard protocol [19] and using the 
maximum value obtained for analyses. Participants completed the Timed Up-and-Go (TUG) 
test: a stopwatch was used to measure the time taken to get up from a chair and walk as 
quickly and safely as possible up to and around a marker placed 3m away, walk back to the 
chair and sit back down. We converted this time to an estimate of gait speed (m/s) using the 
formula (6 / [TUG time]) * 1.62 [20,21]. We measured total body weight (kg) and estimated 
appendicular lean mass (kg) using a Tanita MC-780MA body composition analyser (Tanita 
Corporation, Arlington Heights, IL.). We estimated height based on demi-span, measured 
twice to the nearest millimetre. We calculated skeletal muscle index (SMI) (kg / m
2
) from 
appendicular lean mass divided by height-squared. We applied the European Working Group 
sarcopenia definition to our results, using recognised cut-points for grip strength of < 30 kg in 
men and < 20 kg in women, for gait speed of ≤ 0.8 m/s and for SMI of < 7.26 kg / m2 in men 
and < 5.45 kg / m
2
 in women [22]. We considered participants with weak grip and/or slow 
gait speed, in combination with low SMI, to have sarcopenia. 
 
Phosphorous magnetic resonance spectroscopy 
Participants attended for 
31
P-MRS scanning and were requested to perform a low-intensity 
plantar flexion exercise in the scanner with incremental loading, until the phosphocreatine in 
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the gastrocnemius and soleus muscles was depleted by approximately 50%. Measurements 
were taken every 10 seconds during exercise and recovery. We fitted an exponential recovery 
curve to the area under the phosphocreatine peak from which we modelled the time taken, 1/2 
PCr (seconds), for recovery halfway to baseline, as a measure of mitochondrial oxidative 
function, with shorter times implying higher function [5]. 
 
Muscle biopsy 
We obtained biopsy of the vastus lateralis muscle under local anaesthesia from seven 
participants using a Weil Blakesley conchotome. The samples were snap frozen in isopentane 
cooled in liquid nitrogen. We telephone participants the following day to check their 
wellbeing and visited them at home one week after their biopsy to check the wound had 
healed and that there were no signs of infection present. We also enquired about any pain at 
the site, rated on a scale of 0 (no pain) – 10 (worst pain). 
 
Quadruple immunofluorescence 
Two 10 µm sections from each biopsy were used for the quadruple immunofluorescence with 
antibodies to laminin, NDUFB8 (subunit of complex I), MTCOI (subunit of complex IV) and 
porin, as described previously [11,23]. Control samples were biopsies obtained from five 
younger patients undergoing orthopaedic surgery (see Supplementary Table 1 for full details). 
The control and participant sections were reacted the same day with the same batch of 
antibody and identical concentrations. All exposure times were set and maintained throughout 
the imaging. 
 
The immunofluorescence data from the fibres in the control samples were used to produce 
linear regression models for the relationships between levels of complex I and porin, and 
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between complex IV and porin. The regression findings were then used to predict the 
expected levels of complex I and IV per fibre among study participants based on the fibres’ 
measured porin levels. The measured values in complex I and IV were then expressed as Z-
scores (the number of standard deviations the measured values were above that predicted by 
the linear regression models). We classified fibres with Z ≥ -3 (so measured values no lower 
than 3 standard deviations below that predicted from the relationships seen in young controls) 
as positive. 
 
Statistical analyses 
We calculated descriptive statistics for the variables of interest and tested for differences 
between participants who did and did not undergo muscle biopsy using the Wilcoxon Rank-
Sum test. We performed all analyses using Stata version 14.0 [24].  
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Results 
Table 1 shows the characteristics of the 19 participants recruited to the study. They had a 
median of two diseases and high levels of self-reported physical function and general health, 
especially among the women in the sample and when compared to normative data for the 
same age group [25]. They regularly engaged in aerobic physical activity with a mean RAPA 
score of 4.8 (1.4). Their mean results for the components of sarcopenia were either above the 
relevant cut-points (gait speed, SMI) or just below (grip strength); as such only one 
participant had sarcopenia according to the EWGSOP definition. 
 
Mitochondrial function assessed using magnetic resonance spectroscopy 
We collected valid 
31
P-MRS data in 16 participants (one was unable to attend, one declined 
the scan and in one participant their phosphocreatine did not deplete adequately during 
exercise). The mean 1/2 PCr was 35.6 (11.3) seconds, in keeping with preserved 
mitochondrial oxidative capacity [5]. The scan procedure was well tolerated by all 
participants who undertook the test. 
 
Mitochondrial content assessed using quadruple immunofluorescence 
Seven participants had a muscle biopsy collected. Reasons for non-participation included the 
presence of visible veins over the planned biopsy site (n=5), use of medications that could 
increase risk of bleeding or poor wound-healing (n=3) and participants being unavailable 
(n=1) or unwilling (n=3) to have biopsy. We saw no differences in the baseline characteristics 
(as shown in Table 1) between those participants who did and those who did not have muscle 
biopsy. There was little evidence of deficiency in men or women of either of the two 
mitochondrial respiratory chain complexes tested, as shown in Table 2. There were no 
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complications noted at the follow-up home visit and none of the seven participants reported 
any pain at the biopsy site.  
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Discussion 
In this pilot study we carried out an initial investigation of skeletal muscle mitochondrial 
respiratory chain function and content in an active and healthy sample of 85-year-olds, 
among whom sarcopenia was uncommon. We found that phosphocreatine recovery time from 
31
P-MRS (in 17 participants) and levels of subunits of complexes I and IV from quadruple 
immunofluorescence (in 7 participants) were preserved. Both assessments were well 
tolerated. 
 
Reduction in content and changes to the functions of skeletal muscle mitochondria including 
reduced respiratory chain function, sensitisation to permeability transition and impaired 
quality control may contribute to the development of sarcopenia [4,26]. In addition to those 
used in the present study, a range of techniques have been used to investigate these changes. 
For content these include histochemistry of enzymes such as cytochrome c oxidase [1] and 
mtDNA copy number [27]. For functions they include ex-vivo measurement of respiration in 
permeabilized myofibres [10,12] and Western immunoblotting of proteins regulating quality 
control processes [13]. 
 
There is debate on the extent to which age-related changes in mitochondria represent a 
primary organelle defect or occur secondary to concomitant reductions in physical activity 
and cardiorespiratory fitness. Several studies have compared the mitochondrial function and 
content in young active individuals to that seen in older active and older sedentary groups 
[2,10,28,29] and to that seen in sedentary individuals across a range of ages [12]. They have 
shown that increased habitual physical activity appears to attenuate age-related declines in 
mitochondrial function and content, with evidence from exercise intervention studies 
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supporting this  [30,31]. Therefore, the regular aerobic activity undertaken by participants in 
our study may have contributed to the preserved mitochondrial function and content.  
 
We are not aware of other data for 
31
P-MRS of the gastrocnemius and soleus muscles in the 
very old. Taylor et al. previously reported a similar mean 1/2 PCr of 32 seconds in these 
muscles following exercise in a sample of six healthy men and women aged 70-83 years [32]. 
Two previous studies have reported 
31
P-MRS data for the quadriceps from three samples with 
mean ages between 72 and 79 years [33,34], expressed as the recovery rate constant, kPCr. If 
we assume that the two muscle sites are comparable and convert kPCr to 1/2 PCr (using the 
formula 1/2 PCr = -ln(0.5) / kPCr), then their summary values are again similar to our own: 
ranging from 33.0 to 36.5 seconds. It is likely that we do not see abnormally long values in 
our older sample as they regularly engage in aerobic physical activity. This has been shown 
to have marked benefits for function assessed by 
31
P-MRS of the quadriceps in a sample of 
young men [35], and more recently when comparing older active and sedentary individuals at 
mean ages 68 and 71, respectively [29]. 
 
We also saw largely positive fibres on quadruple immunofluorescence, with mean Z-scores 
of the complex I and IV subunits in the positive range (Z ≥ -3), as we previously reported in a 
sample of community-dwelling older men at mean age 73 [11]. The high level of physical 
activity undertaken by our participants may have attenuated the age-related decline in 
mitochondrial respiratory enzyme content [2,29,36]. 
 
We found that it was feasible to undertake 
31
P-MRS including exercise of the calf muscles in 
a healthy sample of 85-year-olds and that the procedure was well tolerated. The majority of 
participants were also willing to undergo biopsy and those who did reported little discomfort 
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following the procedure, in keeping with existing research [37,38]. We exercised caution 
when deciding to proceed with biopsy, for example excluding participants with visible veins 
around the biopsy site. Understanding more about the acceptability and feasibility of muscle 
biopsy in the very old would allow cellular and molecular mechanistic studies in this age 
group to flourish. 
 
This study had several strengths. We successfully recruited a sample of healthy 85-year-old 
people for detailed phenotyping related to skeletal muscle. We carried out an initial home 
visit, giving participants opportunity to meet a member of the study team and discuss what 
the study involved; this has previously been linked to engagement with intensive assessments 
such as muscle biopsy [38].  
 
Limitations of this study include the fact that we assessed physical activity using a 
questionnaire; an objective measurement would have given us useful additional information 
regarding the intensity and patterns of activity. We did not attempt muscle biopsy in around 
two-thirds of participants, mainly due to skin changes or medication history. Our sample was 
also biased towards healthier and more active participants, among whom sarcopenia and 
other conditions were less common than average for this age group [7,39]. This may in part 
reflect the study’s exclusion criteria: for example, those taking anticoagulant drugs are more 
likely to have cardiovascular disease than the general population. The small sample size of 
our study prevented us from examining associations between mitochondrial function / content 
and the components of sarcopenia. The small sample sizes and variability of the measures we 
report also suggest that the mean values we show in Table 2 may well not be representative 
of the underlying population. 
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In conclusion, we found that skeletal muscle  respiratory chain function, assessed using 
31
P-
MRS, and the content of two respiratory chain subunits in muscle biopsy samples were 
preserved in a healthy, active sample of 85-year-old men and women. This is likely to reflect 
the fact that our sample reported regularly engaging in aerobic exercise. These results will 
help to inform future studies in this age group, including in those with lower activity levels 
and higher levels of sarcopenia than in this pilot study.  
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Table 1 Sample characteristics 
Characteristic  
Mean (SD) unless shown otherwise Men (n=8) 
Women 
(n=11) All (n=19) 
 
   
Age at interview (years) 84.9 (0.3) 85.0 (0.3) 85.0 (0.3) 
    
Disease count [median (IQR)] 3 (2,3) 1 (1,3) 2 (1, 3) 
No. of prescribed medications [median (IQR)] 7 (3,14) 5 (4,6) 6 (3, 11) 
Geriatric depression score 2 (1,2) 1 (0,2) 1 (0, 2) 
Mini-mental state examination score 29 (29,30) 30 (29,30) 29 (29, 30) 
Number of ADLs with difficulty / help needed  2 (0,3) 0 (0,2) 1 (0, 2) 
SF-36 self-reported physical function (0-100)* 64.2 (23.4) 79.4 (16.5) 73.1 (20.6) 
SF-36 self-reported general health (0-100)* 70 (9.6) 79.6 (10.1) 75.5 (10.8) 
RAPA aerobic activity score (1-7)* 4.6 (1.6) 5 (1.3) 4.8 (1.4) 
RAPA strength and flexibility score (0-3)* 0.9 (1.0) 0.6 (0.8) 0.7 (0.9) 
    
Grip strength (kg)  29.9 (6.2) 19.1 (6.1) N/A 
Gait speed (m/s) 0.9 (0.4) 1.1 (0.3) 1.0 (0.3) 
BMI (kg / m
2
) 27.6 (3.1) 24.4 (4.2) 25.7 (4.0) 
SMI (kg / m
2
) 8.1 (0.8) 6.4 (1.0) N/A 
EWGSOP sarcopenia [n (%)] 1 (12.5%) 0 (0%) 1 (5.3%) 
    
 
* Higher values on the SF-36 and RAPA scores indicate higher levels of function/health and 
activity, respectively. 
 
ADLs, activities of daily living. BMI, body mass index. EWGSOP, European Working 
Group on Sarcopenia in Older People. IQR, interquartile range. RAPA, rapid assessment of 
physical activity. SF-36, Short Form 36 Health Survey Questionnaire. SMI, skeletal muscle 
index 
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Table 2 Mitochondrial function and content 
Characteristic  
Mean (SD) Men Women All 
 
   
Phosphorous magnetic resonance spectroscopy  n=6 n=10 n=16 
    
Phosphocreatine recovery rate, 1/2 PCr (s) 33.1 (8.6) 37.0 (12.9) 35.6 (11.3) 
    
Quadruple immunofluorescence n=3 n=4 n=7 
    
Complex I 
Mean fibre Z-score 
Proportion of positive fibres (Z ≥ -3) (%) 
 
 
-0.5 (1.1) 
98.9 (1.4) 
 
-0.7 (0.4) 
98.6 (0.2) 
 
-0.7 (0.7) 
98.7 (0.9) 
Complex IV 
Mean fibre Z-score 
Proportion of positive fibres (Z ≥ -3) (%) 
 
0.0 (0.4) 
99.4 (0.4) 
 
-0.3 (0.5) 
98.8 (0.3) 
 
-0.2 (0.4) 
99.1 (0.5) 
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Figure 1 Assessment of mitochondrial function and content 
 
Sample results for mitochondrial function and content (NB two different participants are 
shown). A. Exponential recovery curve for phosphocreatine following exercise. 1/2 PCr for 
participant shown is 36.6 seconds. B. Quadruple immunofluorescence. Mean Z-scores from 
participant shown of 0.6 for complex IV (MTCOI) and 0.1 for complex I (NDUFB8). 
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